Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Knowing the right time to start planning for retirement is essential. Discover the best age to begin securing your financial future.
26,342 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Investors eye the Q4 2025 earnings transcript from Up Fintech (TIGR) to gauge growth, margins, and execution. This gu...
CrowdStrike has become a pillar in AI-era cybersecurity, but a 14% decline raises the question: is it a buy? This gui...
Lawmakers warn that granting a national bank charter to a crypto-focused issuer could undermine financial integrity a...
As investors eye the next earnings cycle, Sweetgreen's 2025 earnings outlook becomes a focal point for growth, margin...
Wall Street chatter about a SpaceX and Tesla merger has sparked a wave of questions. This article unpacks what the ph...
Investors confront a familiar fork: cash out a top-performing rental to ease debt on another, or hold for long-term g...
A notable insider maneuver at CareDx drew attention to the stock. This article breaks down the sale, what it means fo...
Qualcomm is shifting focus from phones to AI compute, targeting massive new markets. This article breaks down the pla...
Two popular 3x ETFs chase daily moves in different corners of the market. This guide breaks down when levered bets on...
As two iconic U.S. food brands, Krispy Kreme and McDonald’s attract very different types of investors. This article b...
Guidewire's 2026 earnings narrative centers on cloud shift, product mix, and disciplined growth. This guide breaks do...